27 April 2025
: Case report
From Erysipelas to Epiglottitis: Managing Complications in Invasive Group A Streptococcal Infection
Unusual clinical course
Shuhei Matsumoto1ABCDEF, Takuya Masuda2D, Nobuyoshi Minemura2ABCDEF*, Hiroyoshi Nakajima2DE, Keita Tatsuno
DOI: 10.12659/AJCR.947291
Am J Case Rep 2025; 26:e947291
Abstract
BACKGROUND: Group A Streptococcus (GAS, Streptococcus pyogenes) is a gram-positive human-exclusive pathogen responsible for various types of infections. The incidence of invasive GAS infections, which can be severe and are associated with Streptococcal toxic shock syndrome (STSS), is increasing worldwide.
CASE REPORT: A 75-year-old woman with a past medical history of cervical cancer surgically treated 10 years ago and dyslipidemia presented to the Emergency Department with fever, swollen eyelids, and difficulty moving her body. Initially, she was diagnosed with erysipelas based on her typical facial manifestation. Cefazolin was initiated, but it was changed to Ampicillin + Clindamycin due to concerns about invasive GAS and STSS. Despite these antibiotics, her edema deteriorated and her neck became swollen on Day 3. She reported difficulty breathing, and inspiratory stridor subsequently appeared. CT showed facial and pharyngeal edema. We urgently intubated her with a bronchoscope, which revealed a swollen and reddish epiglottis. Her airway symptoms and swollen neck disappeared on Day 11, and she was extubated. On Day 18, her antibiotic treatment was completed.
CONCLUSIONS: We describe a patient with invasive GAS infections whose initial manifestation was typical of erysipelas, but she eventually required intubation due to complicated epiglottitis. Even when GAS disease is treated with antibiotics, it may be difficult to prevent subsequent invasive GAS disease. Regardless of the initial diagnosis and treatment, careful monitoring is vital. When invasive GAS infection is suspected, there is a need to prepare for urgent intervention.
Keywords: Epiglottitis, Erysipelas, Streptococcus pyogenes
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946411
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946041
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947953
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946932
Most Viewed Current Articles
21 Jun 2024 : Case report
96,778
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,393
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
31,818
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,483
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030